Chemport Inc. was established in 2001 and has been a leading Omega-3 fatty acid manfuacturer with our own high technology.
We are capable of producing up to 97% of EPA, 95% of DHA, and 95% of EPA & DHA blends omega-3 fish oil.
We are one of the extremly few capable companines in the world which can supply two FDA approved prescribed fish oil drus, Omega-3 Acid Ethyl Esters called Lovaza and Omacor and EPA min. 96% called Vascepa along with high concentrated fish oil supplements.
We are a manufacturer of API's and Formulations in India and we export to Japan, China, Indonesia, North America Latin America and African sub-continent. Our facilities are WHO/EU GMP approved and we are an ISO 9001-2008 compliant company.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
One of our finished formulation unit caters to Pfizer, Glaxo Smith Kline, Nicholas Piramal, Ranbaxy, Dr. Reddy's, Abott, Merck, Novartis, US Vitamins, Wockhardt, etc. for the domestic market in India.
We also have a USFDA approved unit manufacturing food colors for human consumption.
Pharmaceutical finished formulations from WHO/EU GMP units are registered/being registered in 26 countries including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad and Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
Mission & Vision
CHEMTOUR is a leading marketing company for pharmaceutical industry from China. We focus on customer-synthesized advanced intermediates, such as amino acid derivatives,coupling reagents and protecting reagents.
Currently we have 2 R&D centers, 5 manufacturing sites, which have the capability from lab, pilot to commercial production. All our team members have rich experience in chemical and pharmaceutical industry. We also have dedicated quality and EHS team to ensure the product to meet customers' requirements.
Chemtrade is the only North American manufacturer of API grade KCl. Our potassium chloride product is supplied globally and is available in Custom morphologies (spheres and cubes) for sustained release or immediate release application. Chemtrade's KCl is currently compliant with USP/EP/FCC/JP/BP and ACS monographs. Chemtrade also manufactures high purity compendial grade (NF/BP/JP/EP/FCC and ACS) KOH and NaOH pellets which are used as excipients for pH adjustment and buffers. Additionally Chemtrade is one of the largest North American manufacturer of aluminum based adjuvants for vaccines and plasma protein separation.
Chemwerth is a full service generic drug development and supply company with offices in the U.S., China & India that delivers high quality APIs to regulated markets worldwide. Chemwerth provides expertise in research & development; technical and regulatory services; sales & marketing; and strong project management providing customers with speed to market advantage.
With a 45 year track record of serving the healthcare sector, Zhejiang Cheng Yi Pharmaceutical Co Ltd has established itself as a reliable manufacturer and supplier of pharmaceutical products and a contract manufacturing partner to the pharmaceutical industry. At Cheng Yi pharmaceutical, we dedicate our operational efforts to manufacturing excellence, strict compliance with cGMP requirements, and customer satisfaction. Our API manufacturing facilities were first audited by TGA in 1998, and have since been regularly inspected and consistently approved by other world regulatory authorities. In particular, we are proud of the success in the first-ever global joint audit of our facilities by FDA, EMEA and TGA in 2010. Our business comprises development, manufacturing and supply of APIs, pharmaceutical intermediates and dosage form products. Headquartered on Dongtou Island of Zhejiang Province and with sales center in Shanghai, Cheng Yi Pharmaceutical employs 560 and operates 2 manufacturing sites with total site area of 225000 sq meters, total reactor capacity of 451 cubic meters and fermentation capacity of 300 MT, as well as 2 dosage form production lines.
Chengda Pharmaceuticals Co Ltd was set up in 1999, located in the beautiful scenery of the Hangzhou-Jiaxing-Huzhou plain, Jiashan Economic Development Zone. Nowadays the company owns two plant sites, located in No.5, Hengshan Road and No.36, Huanghe Road
The company mainly produces APIs, food additives, feed additives, antibiotics, anticancer, antiviral of pharmaceutical intermediates, and etc. Products are sold in more than 30 countries and regions. The in-house developed product, Levocarnitine, has won the honorary title of “national, key and new product” and passed the US FDA on-site inspection without deficiency in March, 2013.
Chengdu Better Pharmaceutical Technology Co Ltd. is a high-tech corporation which engaged in drug declaration and manufacture of pharmaceuticals, intermediates and impurities. We have earned ourselves a good reputation at home and abroad with advanced technology, standardized management and well established service system.
Biopurify is a leading company in R&D, manufacture and marketing of High Quality Phytochemicals and Extracts (especially Active Ingredients from Chinese Herbs), Natural Active Pharmaceutical Ingredients worldwide. From small quantities for R&D or reference standard to large quantities for customizing or manufacturing, Biopurify emphasizes the service featuring consistency and reliability.
Chengdu Chengnuo New-Tech Co Ltd is a manufacturer of protected amino acids and oilfield chemicals. Our product line includes L-cysteine hydrochloride anhydrous, L-aspartic acid, L-glutamic acid, DL-methionine, L-phenylalanine, L-threonine, triphenylmethyl chloride, D(+)-tryptophan, benzyl chloroformate, dicyclohexylcarbodiimide and 4-dimethylaminopyridine.
Chongqing Quanxinxiangsheng Bio-Pharmaceutical Co., Ltd., is a Professional GMP manufacturer of bio-pharmaceutical products for pharmaceutical, food processing, nutritional and diagnostic industries worldwide. Pancreatin and Pepsin are our featured goods. Chengdu Di'ao Chemistry of Plant Co.,Ltd., is an enterprise possessing independent import and export right and integrating scientific research, industry and trade, which mainly specializes in the manufacturing, development, production and business of active ingredients extracted from natural plants, i.e. the manufacturing of midbody of medication and health care products.
Chengdu Easton Biopharmaceuticals Co Ltd is a new leading pharmaceutical company, engaging in development, manufacture and distribution of commercial-scale Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). Our manufacturing facilities are fully compliant with EU-GMP and US-GMP standards.
Our products include Bisoprolol Fumarate, Clopidogrel Bisulfate, Flupirtine Maleate, Naloxone Hydrochloride, Olanzapine, Prasugrel Hydrochloride, Moxifloxacin Hydrochloride, Vilazodone Hydrochloride, Esomeprazole(sodium/magnesium), Fusidate Sodium etc.
Chengdu Hawk Bio-Engineering Co Ltd is one of the strongest professional manufacturers of natural plant extract and active ingredients for medical, health food and cosmetics applications. HAWK was founded in 1989, and changed its system and name according to the modern company system in April 2001.
Since the foundation of the factory, we have been manufacturing plant extracts according to national and other international standards strictly. After 19-year's development and HAWK people's effort and innovation, now we have owned strong manufacturing strength, professional standardized workshops under GMP's guideline, individual R&D centre and raw material planting bases. In 2003, HAWK passed ISO9001:2000 quality management system and HAWK's products are KOSHER certified. By right of competitive product quality and services, HAWK and its products are approved by the customers worldwide.
And now HAWK has become one of the strongest manufacturers of plant extract in China. The manufacturing is located in Jintang County where is called "Orange Village" and not far from Chengdu. Our factory covers 8000 square meters. The whole staff is around 100 people. Chengdu Hawk Bio-Engineering co., Ltd. depends on Szechwan and western regions' abundant plant and medicine material resources, and 19-year's rich experience on plant extracting.
We do well in the following products: Citrus Aurantium P.E., Hesperidin, Hesperitin, Methyl Hesperidin, Neohesperidin, NHDC, Naringin, Rutin, Troxerutin, Quercetin, Rhodiola Rosea Extract, Green Tea Extract, Grape Seed Extract and Ginkgo Biloba Extract, etc.
"Excellent quality, Sincere conduct, Enthusiastic service" is the spirit. "Come from the nature and return to the nature" is what we are pursuing. Hawk Company wishes it can cooperate with domestic and international customers earnestly and concentrate on the human health business together! Hawk-Bio ----- Your Reliable Plant Extract Products Producer!
Hubei Nokete Pharmaceutical Co., Ltd.(NKT) is a professional GMP manufacturer of phytochemicals (phytomedicines' raw materials and botanical extracts, etc.). NKT mainly focus on the extraction, separation and purification of natural ingredients, and meanwhile carry out the research and development of phytomedicines. Our products have been widely used in pharmaceuticals, health care products, food supplements, food additives, cosmetics and other fields. There are more than 100 customers around the world use and trust NKT's products nowadays. We take the technology as the forerunner and the quality as the core, to create value to the customers for mutual development.
Chengdu Okay Co Ltd is a specialized high-tech enterprise, which is specialized in plant extraction, purification and synthesis, concentrated on providing European and American markets with raw materials of health products, functional foods, drugs and cosmetics.
Chengdu Okay Plant & Chemical Co Ltd was founded in March of 2004, it has established production bases for 3 different products series of Citrus Aurantium, Sophora and Artemisia, relying on abundant herbal resources in Sichuan province.
While Chengdu Okay Pharmaceutical Co Ltd was founded in November of 2011 according to the standards of GMP (2010), it is located in Qionglai, Chengdu Pharmaceutical Industry Park, with an area of about 35,000 square meters, which is specialized in natural herbal extraction, synthesis and further exploitation.
Chengdu Pukang Biotechnology Co., Ltd. was founded in 2008, is a high-tech enterprise specializing in unnatural amino acids and their derivatives. The company has established a R & D center with 1000 square meters and a production base of 12000 square meters. The quality system is managed according to the GMP standard. The main products of the company are Lifitegrast intermediate ,Semaglutide series,N-heterocyclic butane series, hydroxyproline series derivatives,PEG derivation and other unnatural amino acids derivatives. Over the past 10 years, the company has provided over120 kinds of compounds for more than 40 pharmaceutical companies and over 100 agents in the world, providing high quality technical services for the development of new drugs and the development of generic drugs. Adhering to the “Quality first, Technology leading” business philosophy, we provide the best products and the best service for the global customers.
We are a company which integrates with the research, development, production and marketing of yeast and yeast products. Main products include: molasses yeast, veimei yeast, yeast powder (Antibiotic fermentation medium), composite yeast powder, compound amino acid powder, yeast extract, phytin, autolysis of yeast powder, peptone, corn syrup, silk fibroin powder, etc.
Chengdu Puth Medical Plastics Packaging Co Ltd mainly produce Eurocap and port for infusion bottles and bags; Medical devices (including blood collection tube, needle, syringe etc.); OEM for other medical and pharmaceutical plastic products.
Chengdu Shengnuo Biopharm Co Ltd is a subsidiary of Chengdu Shengnuo Tech Development Co Ltd and was founded in October 2004.
With 50 key technologies for large-scale production of domestic and foreign peptide drugs, we are a leading manufacturer of peptides by solid-phase chemistry. In addition, our team has the ability to perform product development, technology transfer, technical services and large-scale multi-kilogram single batch production capacities.
As an industry leader in the domestic solid-phase peptide market, we have recently received approval as a registered US FDA manufacturing facility with zero 483 citations.
The company is devoted to studying, developing, producing, and marketing the natural herbal medicines and has been bestowed with an import & export license. The products include Hesperidin, Synephrine, Rutin, Berberine Hydrochloride, Chlorogenic Acid, and Raicalin etc.
ChengDu TongChuangYuan Pharmaceutical Co.Ltd is located in Tianfu Life Science Park,ChengDu,Sichuan,China.
TongChuangYuan is a rapidly growing manufacturer of high quality pharmaceutical intermediates,
pharmaceuticalbuilding blocks,fine chemicals for research and industrial application in contemporary drug discovery and development.
Our main product is : pyridine, boronic acid,pyrimidine,quinoline,API and intermediates.
Low temperature reaction (-80 deg c)
High temperature and pressure reaction
Yacht Bio-Tech Co Ltd is a R&D and process improvement company for bio-medicines. We are mainly engaged in new drugs research, process improvement, drug structural analysis, products quality, and establishing the standards of products. Our fields refer to anti-tumor, anti-infective, cardiovascular, and immune system drugs. Also in the field of technical research and product development, we are able to enlarge the production from laboratory scale to pilot plant scale. By now, we provide optimum technical service from laboratory production/scale to pilot plant scale. In same cases, we even provide the small commercial scale.
Our main focus is on the field of developing microbe and synthetic chemicals, doing innovative research in partial synthesis of antibiotic new drugs, products and technics, and also doing research in sreening new drugs from microbe. We combine genetic engineering technics with tranditional technics, which is used for breeding strains in antibiotics from microbe. We also develop engineering bacteria and heterozyme that is used for microbes and enzyme transformation in drug research. We are also specialized in immobilization technology that is used in the micro-cells or enzyme of important pharmaceutical intermediates transformation or synthesis and resolution in chiral-compound. We choose optimum technics in important antibiotics manufacture. We have gained satisfactory achievement in partial antibiotic synthesis tehnics, microstrains by using modern technics, production technique, and bilocatalysis technology used in manufacturing chiral pharmaceutical intermediates. Ever since establishment, Yacht achieved the major breakthroughs in key technics of important drugs, in which the innovation research project CLVA (New biosynthetical technique for high-production of Clavulanic acid) was funded by Inno-Fund of Chinese Science and Technology Association, new technics of reduction drug Orlistat and antibiotic Daptomycin, and fermentation and extraction technics of cephalosporin C. All technics mentioned above have been transferred to enterprises in China and abroad, which makes Yacht gain a high reputation. Besides, our high quality API products are well sold in USA and EU. Our cooperators are big enterprises in China and well-known companies and labs abroad. Yacht has passed the ISO 9001 Q.C. certification, and all procedures are put in practice under Project Management Standards. Yacht has developed many high quality API products on the basis of abundant technology, advanced production technics and complete test measures. Meanwhile, Yacht strictly conforms to the ISO9001: 2000 quality system certification, regards technology as forerunner, accelerates the development of the new products with the technology, and always maintains and improves the quality of the products.
Chengdu Yazhong Bio-pharma was founded in 2002, whose main products are Diosmin, Resveratrol, Ergosterol. We have over 10-year experience on Diosmin, which is granted GMP and WC. For Diosmin series, we have Diosmin EP 90%-102%, Diosmin/Hespridin, Diosmin Micronized. GMP, MSDS, WC and DMF are available.
Chereso Lifesciences, incorporated in 2003, is a company dedicated to the principles
of tradition, innovation and research. The manufacturing is WHO-GMP, NSF- US GMP, ISO
9001:2008, ISO 22000:2005, Kosher and HALAL certified. The
Company's vision is to be a trusted healthcare provider, driven by excellence,
through innovation and quality.
Its business focuses on manufacturing of APIs, Nutraceuticals and standardized herbal extracts as per Pharmacopoeia Standards. The company is manufacturing a wide range of products supported with patents & clinically evaluated and is fast growing to meet the present and future market demands for plant-based scientifically processed products. Some of the major products of our company are Alpha Yohimbine, Colchicine, Thiocolchicosides, Sennosides, Fenugreek extract, Lysergol, Chlorogenic Acid, Protodioscin, Reserpine USB/BP among others. The company has expanded its business activities in countries like Asia, Africa, Europe, USA and other growing markets. For more information, please visit us at www.chereso.net, www.fenfuro.com
Chifeng Addisun Pharmaceutical Co Ltd is one of the subsidiaries of Hangzhou Minsheng Pharmaceutical Co Ltd. Chifeng Addisun, dedicated to the production of hydroxyethyl starch, is becoming the biggest manufacturer specialized in producing HES series in China. Chifeng Addisun is the first one to realize the industrialization of medium Molecular Weight HES 200/0.5 in China. The preparation, the main product of plasma substitute in current world, is the preferred remedy for curing and preventing hypovolemia and shock. We can produce customized hydroxyethyl starch with molecular weight ranging from 100,000 to 450,000 Dalton and molar substitution ranging from 0.3 to 0.7.
Chimet produces supported (heterogeneous) and unsupported (homogeneous) catalysts based on PM (precious metals as Pd, Pt, Rh, Ru) , with application in the fine chemical and pharmaceutical industry (APIs). Chimet as recovery & refining of PM leader , offers a complete PM loop service to its customers with the guarantee of a maximum yield and quick settlement on the PM recovery from spent catalyst. Tailor-made catalysts can be produced based on customer's requirements. Many different physical, chemical and catalytic activity tests are available to the customers for the R&D, Quality Control and Technical Assistance.
China Animal Husbandry Industry Co Ltd manufactures and sells animal health products and feed additives in China. It offers various biological products consisting of vaccines for fowls, diagnostic liquid products, avian influenza vaccines, foot-and-mouth disease vaccines, swine vaccines, and others; feedstuffs, such as feedstuff raw materials, feedstuff additives, pre-mixed feedstuffs, and multi-vitamin feedstuffs; and veterinary drugs comprising animal remedy products and drug additives. The company is based in Beijing, China.
Founded in May 1989, CCCMHPIE is the leading and most influential national trade associations in China with a mission to promote the international trade and cooperation in medicinal and health products. CCCMHPIE, directly under the Ministry of Commerce of China, has a diverse membership of more than 2400 companies. The fields that CCCMHPIE cover range from Traditional Chinese Medicines (TCM), pharmaceuticals, preparations, medical devices and equipment, dressings, biopharmaceuticals, nutraceuticals, functional cosmetics to health products.
China Meheco Corporation, belonging to Genertec Holding Co, is one of the biggest state-holding enterprises in medical and pharmaceutical field in China. The comparative advantages are as follows:-
1) All formulation production line with GMP approval
3) Fermentation Plant
4) Documentary support
5) 5300 hectares herb planting base and relative extract plants
6)Import & Export over 100 products of API & intermediates
7)Domestic distribution network
8)Government background and Flexible business strategy
China National Pharmaceutical Foreign Trade Corporation (abbreviated as SINOPHARM (FOREIGN TRADE)) was established in 1981. We are a wholly-owned subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM) and specialize in international pharmaceutical economic and technological cooperation, international trade and domestic sales in pharmaceuticals and related products.
Entrusted by the state government, we have carried out national assistance projects, the UN assistance projects to China, and the work of national medicine reservation. We have held several large international pharmaceutical exhibitions and participated in international and domestic pharmaceutical tenders.
SINOPHARM (FOREIGN TRADE) is very successful in economic and technological cooperation, especially in introducing foreign investment and establishing pharmaceutical joint ventures. Being the representative of China's pharmaceutical industry, we are the first in the industry to carry out international economic and technological cooperation.
Our imports and exports are mainly pharmaceutical products such as pharmaceutical raw materials, Western and traditional Chinese medicinal preparations, traditional Chinese medicinal materials, pharma-chemical bulks, intermediates, biological products, medical instruments, sanitary materials, pharmaceutical technology and apparatus.
At the same time, we also have some other business in rag trade and chemical, food and hardware industries. In Hong Kong China, Europe, Africa and Southeast Asia, we also have established branches and offices.
China Resources Saike Pharmaceutical Co, Ltd, a wholly-owned subsidiary of China Resources Pharmaceutical Group Ltd, was established in 1958 with a registration capital of RMB 168.55 million. It is a pharmaceutical company with a sound capability of R&D, API manufacturing, finished dosage manufacturing and commercial distribution. Pharmaceutical product in-licensing with business model of repackaging and distributing is one of CRSP's outstanding product pipeline development strategies. With well-established hospital promotion and distribution platforms and a new version Eu GMP and US cGMP-compliant finished dosage facility, we can offer our partners a one-stop solution from product registration, product launching, commercialization, and distribution in the Chinese pharmaceutical market.
BZP is a leading company in reproductive health industry in China, and have obtained authentications including GMP, ISO9001:2000, ISO14001 and OHSAS18001. BZP is also the leading steroid hormone API and intermediates manufacturer in China, with a professional R&D team and GMP qualified workshop. BZP set up Qinhuangdao Zizhu Pharmaceutical Co., Ltd, a production base which covers more than 15 hectares in Qinhuangdao National Economic and Technological Development Zone and possesses international competitive advantages by meeting GMP international standards and gaining the FDA and EDQM authentication.
China National Pharmaceutical Group Corporation (Sinopharm) is the largest medical and healthcare group under the direct leadership of the State-owned Assets Supervision and Administration Commission of the State Council.
Sinopharm has 11 wholly-owned or share-holding subsidiaries and 6 listed companies, covering every aspect of medical and healthcare industry.
In R&D sector, Sinopharm has 2 academicians of Chinese Academy of Engineering, 7 national level research institutes and a large number of outstanding researchers. It is the front runner in China for R&D of chemical drugs and biological products.
In the manufacturing sector, Sinopharm has built up a manufacturing base for a whole industrial chain from biological products, chemical drugs to modern TCM.
As a leading provider of supply chain services, it is the biggest retailer of medicine, healthcare products and medical equipments.
In the engineering design sector, the engineering design institutes of Sinopharm enjoy a high reputation and create a great influence in China. They have edited and compiled more than 10 national standards of the industry and completed more than 400 pharmaceutical engineering designs. Sinopharm tops the list in China's pharmaceutical project design.
SYNCHEM, located in the International Service Outsourcing Demonstration Base in Bengbu city of Anhui province, was established as a joint venture of Bengbu Investment Group and several senior chemists from abroad. Synchem is dedicated to custom synthesis and manufacturing services for small molecules. We serve the needs of customers in the pharmaceutical, agrochemical, and electrical material industries with top quality products and service.
We integrate internationalized management pattern with local chemical industry resources, take innovation as our core competence, and mainly provide chemical intermediates for internationally recognized chemical and pharmaceutical companies. We specialize in advanced fluorinating technology, asymmetrical catalysis technology, and highly effective organic-metal catalysis technology. Our special chemicals, typically used as intermediates, are widely applied in making more advanced chemicals, like innovated pharmaceuticals, liquid crystal display materials etc., for improving their performance.
To better align with our clients strategically, we also offer our specialty in process design and process development, which result in more efficient and rapid production of specialty chemicals that are incorporated into their own products and thereby enhance the position of our customers. With our four flexible and responsive manufacturing facilities, we are equipped to produce specialty chemicals in both small batches for development stage projects and in large-scale amounts for commercialized projects, according to our customers' needs. We believe that our strong research and development capabilities, efficient management of the manufacturing process and proven track record will provide leading chemical solutions for our customers.
China Union Chempharma (Suzhou) Co Ltd, is a company which is specialized in cephalosporin antibiotic drugs' development, production and sales.
Product categories include oral API and sterile API . The main products are: Cefaclor, Cefdinir, Cefprozil, Cefadroxil, Cefalothin Sodium, Cefamandole Nafate, Cefmenoxime Hydrochloride, Cefpirome Sulfate, Cefoxitin Sodium, Ceftriaxone Sodium,etc.
All products have got the new National GMP Certificate(2010 revised version).
With nearly two decades of committed service to the peptide industry, Chinese Peptide Company(CPC) is one of the most trusted providers of high quality peptides for researchers and pharmaceutical companies all over the world. The CPC group is managed by peptide experts who have been actively pursuing peptide design and large scale manufacturing for more than 30 years in the industry. The CPC Group currently employs more than 500 chemists in Hangzhou, China and the United States has achieved many successful US-FDA inspections, ISO-9001 and ISO-13485 certifications. The state-of-the-art peptide facility is uniquely designed to handle research-grade peptides as well as cGMP grade peptides for clinical trials and API development from milligram to hundreds of kilogram scale with its patented high-through-put PeptidEx technology.
- The First US FDA inspected GMP peptide facility in Asia
- CPC is highly experienced at synthesizing challenging peptide sequences and complex modifications designed to your exact specifications
- First choice of many esteemed scientific research institutions and pharmaceutical companies all over the world
- Peptide purity up to 99.9%
- Peptide length up to 200 amino acids
- Quantities from milligrams to hundreds of kilograms
- Wide selection of complex peptide modifications available including long hydrophobic sequences, highly constrained (e.g., macrocyclization, multiple disulfide bridges, hydrocarbon-stapled, etc.) peptides, and custom-designed FRET substrates
- Thousands of known sequences from 100 different peptide categories
- Over 2000 peptide products available from stock
- Catalogue updating regularly with the latest published peptide sequences
- Reference Link: http://www.chinesepeptide.com
- New Chemical Entities (NCE) 1? One-stop development and registration services 2?New Drug Screening; API Development; Regulatory Support, API Commercial Supply
- Generics 1?Generic Drug Development and DMF Filing 2?Commercial Supply
- Capability to handle large scale projects (up to 20kgs per batch )
- Large solid phase and solution phase peptide synthesis reactors (up to 500L)
- 100K, 10K clean rooms
- Regulatory support (China and Overseas)
- Excellent track record with pharmaceutical companies in the world
- CFR 210/211, ICH Q7A
Chiracon has 20 years of experience in the field of drug synthesis and documentation. As a German, Berlin-Brandenburg based company the company can reliably offer all services possible in the field of synthetic drug development for new or generic products. We specialize in organic synthesis, scale up and production. Furthermore, we provide all the documentation needed for active pharmaceutical ingredients (APIs) for clinical trials, and also in order to introduce new APIs to market - ASMF (active substance master files) /DMF (drug master files), Pharmaceutical Quality/CMC (Chemistry, Manufacturing and Controls) /IMPD (Investigational Medicinal Product Dossier). We utilize a management system which is based on an integrated ISO9001 system and includes a GMP environment.
Chiral Quest was founded in 2000, devoted to contract chemical development and manufacturing services to meet demanding at any stage of development (kilo-lab, pilot-plant and full scale commercial).
With headquarters and R&D center located in Suzhou Industrial Park, Chiral Quest has one manufacturing site in Jiangxi province, and three overseas offices in USA, Europe & India respectively. Chiral Quest focuses on R&D, and holds 13 U.S. patents of asymmetric catalysts and ligands; 6 patents of innovative routes for generic drug intermediattes.
Chiral Quest's mission is to create value for global health care industry by using the most economic and environmental friendly methods to produce chiral pharmaceutical intermediates and API's.
Chirogate is a leading US-FDA inspected Prostaglandin (PG) manufacturer and owns more than 6 dedicated & cGMP-compliant production lines for cutting-edged manufacturing of PGs. Several process patents filed and granted worldwide are to provide a commercially revolutionary synthetic approach and an exciting spectrum of advanced intermediates for synthesis of new PG entities. US DMFs filed for Unoprostone Isopropyl, Treprostinil, Latanoprost, Bimatoprost, and Travoprost with additional registration experiences in China, Japan, Canada, Australia, New Zealand and major EU countries. Products: Unoprostone Isopropyl, Treprostinil, Treprostinil Sodium & Dienthanolamine, Beraprost Sodium, Carboprost Tromethamine, Iloprost Tromethamine, Latanoprostene Bunod, Latanoprost, Bimatoprost, Travoprost, Misoprostol, Lubiprostone, Epoprostenol Sodium, Dinoprostone, Tafluprost, Alprostadil, Dinoprost (& Tromethamine), and (+)-Cloprostenol (&Sodium).
Carelife Pharmaceutical is a export-oriented high-tech enterprise in Chongqing with the manufacturing facilities of APIs and finished dosages in compliance with ICH and cGMP. The company is devoted to the development of the global market with 90% of its API products exporting to USA, Europe and Australia. It has established substantial cooperation with several transnational pharmaceutical companies enjoying international reputation in the field of pharmaceutical research & development and market exploitation.
Chongqing Daxin Pharmaceutical Co., Ltd is the largest manufacturing base of Lovastatin in the world. We own two large-scale pharmaceutical manufacturing bases, including a new base complying with international cGMP standards; as well as owning hundred of APIs, finished dosages and intermediates, including cardio-vascular, antibiotics, immunosuppressant, plasma volume expander, etc.
As the world's biggest supplier of Carisoprodol and Meprobamate intermediates, Ensky Chemical specializes in developing and producing fine chemical and key intermediates of API, plus providing custom-made services to pharmaceutical and other industrial companies worldwide. Ensky is a green and environment-friendly enterprise. It views adopting new environmental friendly technologies in producing high-tech chemicals as its top priority. Its production process is in accordance with the standards listed in the GMP quality management system or above them.
Huapont is a fast-growing listed pharmaceutical company manufacturing and marketing Active Pharmaceutical Ingredients (APIs) as well as finished dosages to the domestic and international market.
Chongqing Kangle Pharmaceutical Co Ltd was established in 1988, and is owned by Beijing Unisplendour Pharmaceutical Co Ltd. Kangle is an FDA approved company which is specialized in producing APIs and intermediates via synthesis method.
Our main products are:- Cilostazol, Hydroxychloroquine sulfate, Piperaquine phosphate,Chloroquine phosphate,Amodaiquine HCL and Modafinil intermediates.
Our company is the world's largest anti-malaria drugs API professional manufacturer. We are looking forward to cooperating with you for the brighter future.
Our company sets high-tech and globalization as its strategic targets by focusing on the research and production of APIs and innovative drug intermediates. Its main products will pass the quality certification of FDA, EDQM, and SFDA. We hold the ideas of caring for life and health, taking social responsibilities and pursuit of excellent product qualities as our belief. Integrity, coordination and innovation are the spirits of our company.
Chongqing Pharmaceutical Research Institute Co Ltd (CPRI) provides integrated generic API services from early-stage development to commercialization with its expertise in non-infringing process development and cGMP manufacture.
Services provideded include: -Full-scale cGMP manufacture of APIs & advanced intermediates; Contract research for generic APIs and FDF Contract manufacture for CTM and hard-to-find APIs. CPRI have 3 manufacturing sites:- CPRI Tushan Road Site (US FDA approved), CPRI Changshou Site (under construction) andKangle Pharma Site (FDA inspection in this April).
Our strength lies in polymorph study, analytical R&D for small and HMW compounds, IP analysis and process development.
History: Founded in 1950s, previously well known as the state-owned Chongqing Pharmaceutical Research Institute, CPRI was one of the pioneers involved in drug R&D and cGMP-compliant API manufacturing in China. In 1994, generic API of Clindamycin HCl was approved by US FDA. Now, CPRI is a subsidiary of FOSUN Pharmaceutical (Group), Co., Ltd, which is a leading pharmaceutical company in China. Faculty and Facility: R&D and quality management are well supported with the latest method of pharmaceutical analysis and the most advanced equipment including GC, LC/MS, HPLCs, UV, etc. which are all made in USA or German. Moreover, the capable and well-qualified CPRI personnel often surprise the visitors who visited the company. Location: CPRI is located in Chongqing, the most prosperous and promising magacity in China, the fourth municipality with the largest population of 32 million.
Chongqing Shenghuaxi Pharmaceutical Co Ltd has three production factories and the head of office is located at C-27,Changjiang Industrial Park, Nan'an district, Chongqing. The company focuses mainly on research and development, manufacturing and sales of bulk materials. This company has been inspected by US FDA and PMDA based on the cGMP requirements and to be approved.
Chongqing Southwest No.2 Pharmaceutical Factory Co Ltd. is a modernized and comprehensive pharmaceutical enterprise which is located in Chongqing Degan industrial park, affiliated to Chongqing Kerui Pharma Group. It occupies an area of 130,000 square meters, and has a staff of 300. At present, the company owns 3 API workshops, mainly manufacturing more than 10 kinds of GMP approved products and OEM customized chemical intermediates. We have established the trading relationships with many countries and regions around the world.
We have established an independent, strict and sound quality management system in accordance with cGMP and ICH Q7a, delivered by the two executive organs QA and QC.10 APIs and formulations have obtained Chinese GMP. And we have passed the FDA site inspection in July, 2012
Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd ,specialized in producing medicinal glass vials and caps for glass injection vials&oral liquid vials. The annual sales income is over 500 millions.The factory can produce more than 4 billion medicinal glass vials and 1.5 billion bottle caps per year.Zhengchuan is in a leading position in
Chr Hansen is a global biotechnology company that provides natural ingredients for the food, dairy, dietary supplement, infant formula, pharmaceutical and agricultural industries. We have been fermenting lactic acid bacteria for more than 140 years, and for more than 25 years we have been committed to delivering clinically documented probiotics. Our probiotics provide the knowledge, inspiration, support and customized solutions needed to create successful probiotic product portfolio. Chr. Hansen has basic R&D centers in Denmark, the United States and France. We continuously expand our facility and upgrade our technology.
Chr. Olesen is a worldwide group of partner-driven distribution and manufacturing companies. The company was originally founded in 1885 and is today managed by the fourth generation. Chr. Olesen is active in distributing ingredients and API's in four different business areas: Feed, Food, Pharma and Vet Pharma. Chr. Olesen Synthesis is the Group's manufacturing company. Chr. Olesen Synthesis is based in Denmark and is an expert in developing and manufacturing and registration of high value wet chemical synthesis products like Hydromorphone, Codeine Phosphate, Pramipexole, Terbinafine Risedronate, Tolfenamic Acid, Amphetamine derivatives and advanced intermediates for Buprenorphine and Tamsulosin. Please explore the videos and more information about our esteemed company at our website: www.chr-olesen.dk.
We, Chromo laboratories India pvt Ltd are USFDA / EDQM / Mexican COFEPRIS Approved and GMP certified API manufacturers with several USDMFs, CEP ( Granted ) for our products. Our Intermediates Manufacturing Unit, GENSYNTH LABORATORIES PVT LTD is also a USFDA inspected Pharma Intermediates manufacturing unit and acts as a feeder plant for Chromo Lab's API unit. Our core strengths are Strict GMP and Regulatory compliance, Multi stage synthesis & Backward integration.
CBF is a non-profit organization established in January,2003, aims to promote bio-venture companies. We participate in CPhI Worldwide 2018 with 6 companies such as 1. HUGEL,Inc.(Botulax, Dermalax), DAE HWA PHARMACEUTICAL CO., LTD.(Liporaxel Solution, TDDS(Kebanon plaster, Loxona plaster, Resnalim patch, etc.), EuBiologics Co., Ltd.( EuCRM197(Carrier protein for carbohydrate conjugated vaccines), EuTOX(Botulinum Toxin Type A), EcML(Immunity enhancer), Contract manufacturing Service), Radiant. Inc.(DERMA-CLERA( Sinapic acid), UNION KOREA PHARM CO.,LTD.(Antiviotics), Y-BIOLOGICS(Antibody pipeline).
Chungbuk Technopark are a non-profit government organization playing a key role between local community and have supported various business programs for small and medium-sized companies in S.Korea. Our main purpose is aiming to foster Bio technology and assist business incubation.
Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB), founded in 1964, is one of the largest API manufacturers in Taiwan. CCSB is a FDA /EU approved cGMP API plant to produce synthesis and biotechnology products. CCSB has filed US DMF, EDMF and COS for several products. Our products include Mycophenolate Mofetil, Pravastatin Sodium, Rapamycin (Sirolimus), Tacrolimus Monohydrate, Methocarbamol, Metaxalone, Calcium Polycarbophil, Glipizide , etc. CCSB also offers contract manufacturing in the cGMP plants. Currently, CCSB is making APIs for European clients under contract and supplying intermediates to new drug companies.